Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiao'er Huangjin Zhike Granules for acute bronchitis cough in children
CTR20213360Phase 3Completed
- Sponsor
- Beijing Dongfang Yunjia Technology Development
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of xiaoer huangjin zhike granules in acute bronchitis, sponsored by Beijing Dongfang Yunjia Technology Development. Started Jan 2022; status: completed.
02
Drugs
xiaoer huangjin zhike granules
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20213360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213360.